Zydus Lifesciences Ltd. (ZYDUSLIFE) Share Price Rises 3.02% as Large Cap Stock Gains Today

Zydus Lifesciences Ltd. at Rs 1,154.50 was up 3.02% today, adding Rs 33.80 in a Large Cap move that lifted its market capitalisation to Rs 1,11,241.63 crore.

Zydus Lifesciences Ltd. Share Price moved up to Rs 1,154.50 on 11 August 2026, a gain of 3.02% or Rs 33.80 from the previous close of Rs 1,120.70. With market capitalisation at Rs 1,11,241.63 crore, the move stood out in today’s market action and placed the stock among the session’s notable gainers. The supplied data confirms the price event and shows that the stock qualified under the Large Cap category in the workflow’s price-rise screen.

For investors searching Zydus Lifesciences Ltd. Share Price Today, the key takeaway is simple: the stock opened at Rs 1,115.35, traded as high as Rs 1,154.50, and remained above its opening level throughout the observed session. That intraday pattern points to sustained buying interest rather than a brief spike. At the same time, the supplied data does not establish a company-specific catalyst, so today’s move should be understood first through verified price, volume and market-position data.

This Zydus Lifesciences Ltd. Stock News update also matters because the company sits in the Healthcare sector, where benchmark valuation and profitability numbers vary widely across 197 companies in the supplied same-sector dataset. Univest notes that when a large-cap healthcare name records a clear same-day share price gain, traders and long-term market watchers often look beyond the headline move to ask whether the price action, sector backdrop and peer context justify closer tracking. That is the right lens for this Zydus Lifesciences Ltd. Share Price analysis today.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Share Price Today: Price Action Analysis

Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,154.5. versus the previous close of Rs 1,120.7, a rise of 3.02%. The stock opened at Rs 1,115.35, reached Rs 1,154.5, touched Rs 1,115.35. Reported volume was 1,22,811.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis

Zydus Lifesciences Ltd. Fundamental Analysis, based strictly on the supplied dataset, starts with scale. The company’s market capitalisation is Rs 1,11,241.63 crore, placing it firmly in the Large Cap bucket and making it substantially larger than the companies listed in the supplied sector benchmark and peer set. Market cap alone does not determine quality, but it does show that Zydus Lifesciences occupies a very different size bracket from many healthcare names in the same comparative universe.

That size context matters for investors reading Zydus Lifesciences Ltd. Share Price News because the benchmark market-cap data for 197 same-sector companies shows a median of Rs 142.30 crore and an average of Rs 472.15 crore, with a maximum of Rs 3,032.97 crore in the supplied sample. Against that backdrop, Zydus Lifesciences sits far above the benchmark range on size. In other words, the company is not just another healthcare listing in the dataset; it is operating at a much larger market-cap scale than the benchmark group provided here.

The rest of the supplied fundamental data is better read through what today’s price move says about investor attention rather than through a full valuation call. The stock added Rs 33.80 in a single session and reached Rs 1,154.50 while generating total volume of 13,99,009 shares. That does not by itself prove a change in business fundamentals, but it does show that a company with a six-figure market capitalisation in crore terms was actively repriced upward in today’s session.

For readers looking for Zydus Lifesciences Ltd. Stock Analysis or Zydus Lifesciences Ltd. Financial Results context, the verified data here supports a measured conclusion: the share price rise is significant because it occurred in a very large listed healthcare company, yet the supplied numbers do not establish a specific earnings, profitability, leverage or cash-flow catalyst behind the move. Univest therefore reads today’s action as a market-verified price event that deserves monitoring, especially when combined with the company’s outsized scale relative to the sector benchmark. That naturally leads into how the broader Healthcare sector is valued and how peers are positioned within that same landscape.

Sector and Industry Context

Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The supplied Healthcare sector dataset shows a wide dispersion in valuation, profitability and market capitalisation across 197 same-sector companies. That matters because today’s Zydus Lifesciences Ltd. Share Price rise happened inside a sector where benchmark averages can look very different from medians, highlighting how uneven the opportunity set is.

The benchmark scope is explicitly the same sector, covering 197 companies for market capitalisation and 196 to 197 companies across other measures. In valuation terms, the sector P/E median is 25.70 and the average is 96.66, with a very broad range from 3.08 to 3,396.30 across 156 companies. That gap between median and average suggests the presence of significant outliers. On price-to-book, the Healthcare benchmark median is 1.94 and the average is 2.65, while the range runs from -16.90 to 15.98 across 196 companies. Profitability also varies sharply: median ROE is 10.92% versus an average of 15.47%, and median ROCE is 13.38% versus an average of 17.78%.

For Zydus Lifesciences Ltd. Share Price Today, the most striking benchmark comparison available is scale. The company’s market capitalisation of Rs 1,11,241.63 crore is far above the benchmark median of Rs 142.30 crore, the benchmark average of Rs 472.15 crore and even the benchmark maximum of Rs 3,032.97 crore in the supplied same-sector list. That does not make the stock cheap or expensive on its own, but it does confirm that investor attention is focused on a healthcare company of exceptional size compared with the benchmark cohort provided.

The benchmark companies also span multiple healthcare industries, including Pharmaceuticals & Drugs and Hospital & Healthcare Services. In that context, Univest views today’s Zydus Lifesciences Ltd. Share Price rise as notable not simply because the stock was rising today, but because it came in a market segment where peer valuations and return ratios are highly scattered. For investors following Stocks in News, Market Movers and NSE News or BSE News, that makes sector context especially important before drawing bigger conclusions from one session’s price action.

Peer Comparison

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,11,241.63 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows a Healthcare universe made up mostly of mid-sized and smaller listed companies by comparison with Zydus Lifesciences. That makes market-cap contrast the clearest verified peer takeaway, while the peer valuation and profitability figures help frame how broad the sector dispersion is.

Zydus Lifesciences Ltd. Share Price is attached to a market capitalisation of Rs 1,11,241.63 crore. By contrast, the largest peer in the supplied comparison is Dishman Carbogen Amcis Ltd. at Rs 3,032.97 crore, followed by Hikal Ltd. at Rs 2,799.54 crore and Kwality Pharmaceuticals Ltd. at Rs 2,707.20 crore. Beta Drugs Ltd. stands at Rs 2,631.45 crore, while Dr Agarwals Eye Hospital Ltd. is at Rs 2,601.85 crore. That means Zydus Lifesciences is several times larger than every named peer in this dataset.

The peer metrics also show how uneven sector valuations and profitability can be. Kwality Pharmaceuticals has a P/E of 40.09, P/B of 9.77, ROE of 28.21% and ROCE of 26.35%. Beta Drugs trades at a P/E of 66.92 and P/B of 10.59, with ROE of 18.65% and ROCE of 22.17%. Sai Parenteral’s carries a much higher P/E of 181.97, though its ROE and ROCE are 13.90% and 12.97% respectively. On the other hand, Venus Remedies has a lower P/E of 17.49 with ROE of 9.85% and ROCE of 7.89%, while Hikal reports ROE of 15.22% and ROCE of 16.15% with a P/B of 2.32.

Because the supplied data does not provide Zydus Lifesciences’ own P/E, P/B, ROE or ROCE, the peer comparison should be read as a sector map rather than a direct valuation verdict. Even so, this Zydus Lifesciences Ltd. Share Price and market-cap profile clearly places the company in a far larger size class than the peers listed here. Univest sees that as useful context for investors tracking Momentum Stocks, Top Gainers Today and broader Healthcare stock analysis.

Why Investors Are Watching Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd. Share Price is being watched because today’s move combined a visible price rise, a session-high print at the current price and meaningful exchange volume in a very large healthcare stock. When a company with a market capitalisation above Rs 1,11,000 crore enters the top gainer conversation, it naturally attracts attention across market screens, Stock Updates and market-news searches.

• Verified price action: the stock rose 3.02%, or Rs 33.80, from Rs 1,120.70 to Rs 1,154.50.
• Intraday structure: it opened at Rs 1,115.35, which was also the day low, and later touched Rs 1,154.50, the day high.
• Volume footprint: total traded volume reached 13,99,009 shares, including 12,76,198 on NSE and 1,22,811 on BSE.
• Large-cap relevance: the workflow flagged the move under the Large Cap price-rise event screen.
• Sector positioning: the company’s Rs 1,11,241.63 crore market cap stands well above the same-sector benchmark range supplied.

What should investors monitor next? The first point is whether Zydus Lifesciences Ltd. Share Price can continue holding near the upper end of today’s range in subsequent sessions. The second is whether future company filings or exchange updates provide a clear business-specific trigger for the move. The third is how the stock behaves relative to other Healthcare names in the same sector universe. Univest believes those are the most grounded follow-up checks after a one-day price rise of this kind.

About Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd. is represented in the supplied dataset as a listed Healthcare company, and the surrounding benchmark and peer data place its operating context within a sector that includes Pharmaceuticals & Drugs as well as Hospital & Healthcare Services businesses. While the dataset does not provide a long-form company description, it does establish the company’s market presence in a very clear way through size: at Rs 1,11,241.63 crore in market capitalisation, Zydus Lifesciences is dramatically larger than the benchmark companies supplied alongside it.

That scale is relevant for anyone searching Zydus Lifesciences Ltd. Company News, Zydus Lifesciences Ltd. Latest News or Zydus Lifesciences Ltd. Market Cap, because it means the stock’s movements can carry more weight than those of smaller healthcare counters. The same-sector comparison includes companies such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs and Solara Active Pharma Sciences, most of which operate in Pharmaceuticals & Drugs and sit in the Rs 2,000 crore to Rs 3,000 crore range in the supplied list. Against that backdrop, Zydus Lifesciences occupies a very different market-cap bracket.

For readers using this article as a Zydus Lifesciences Ltd. Stock News reference, the key point is that the company belongs to a broad healthcare ecosystem where valuation and profitability metrics vary substantially across listed peers. That makes company-specific updates, sector comparisons and sustained price action especially important when assessing how the stock is performing in the Indian Stock Market.

Track Zydus Lifesciences Ltd. Share Price on Univest

Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

If you are following Zydus Lifesciences Ltd. Share Price, Univest provides a structured way to monitor the stock beyond a single session move. Users can track live Share Price, market-cap changes, 52-week levels, intraday price action, exchange volumes and broader market insights in one place. For active market participants, that helps convert a headline move into a more disciplined review of Stock Performance.

Univest is also useful for comparing Zydus Lifesciences Ltd. Share Price Today with peer stocks, sector benchmarks and other Stocks Rising Today. As new company filings, exchange disclosures or market updates emerge, investors can use Univest to keep an eye on price behaviour, sector context and the stock’s position within larger market trends without relying only on one data point from one session.

Frequently Asked Questions

Why is Zydus Lifesciences Ltd. Share Price rising today?

Ans. Zydus Lifesciences Ltd. Share Price rose because the stock moved up Rs 33.80, or 3.02%, from Rs 1,120.70 to Rs 1,154.50 today. The supplied data confirms the price event, though it does not identify any company-specific catalyst.

What is Zydus Lifesciences Ltd. Share Price Today?

Ans. Zydus Lifesciences Ltd. Share Price Today is Rs 1,154.50. The stock was up 3.02% on the session, after closing previously at Rs 1,120.70, making it one of the more noticeable large-cap gainers in the Healthcare space.

How much did Zydus Lifesciences Ltd. stock gain in today’s trade?

Ans. Zydus Lifesciences Ltd. stock gained Rs 33.80 in absolute terms and 3.02% in percentage terms today. That move took the share price from the previous close of Rs 1,120.70 to the current traded level of Rs 1,154.50.

What were the day high, day low and opening price for Zydus Lifesciences Ltd.?

Ans. The stock opened at Rs 1,115.35, which was also the day low in the supplied data. It later climbed to a day high of Rs 1,154.50, matching the current price and showing a strong intraday recovery from the open.

What does today’s volume show for Zydus Lifesciences Ltd. Share Price?

Ans. Total traded volume stood at 13,99,009 shares, with 12,76,198 shares on NSE and 1,22,811 on BSE. That volume accompanied a 3.02% price rise, indicating active participation during today’s move in Zydus Lifesciences Ltd. Share Price.

What is the market capitalisation of Zydus Lifesciences Ltd.?

Ans. Zydus Lifesciences Ltd. has a market capitalisation of Rs 1,11,241.63 crore in the supplied data. That firmly places it in the Large Cap category and makes it much larger than the benchmark companies listed in the same-sector comparison.

How does Zydus Lifesciences Ltd. compare with the Healthcare sector benchmark on size?

Ans. Zydus Lifesciences Ltd. is far larger than the supplied same-sector benchmark. Its market cap is Rs 1,11,241.63 crore, versus a sector median of Rs 142.30 crore, average of Rs 472.15 crore and listed maximum of Rs 3,032.97 crore.

What does the Healthcare sector benchmark show?

Ans. The Healthcare benchmark covers 197 same-sector companies. Its median P/E is 25.70, average P/E is 96.66, median P/B is 1.94, average ROE is 15.47% and average ROCE is 17.78%, showing wide dispersion across sector valuations and returns.

Which peers appear in the supplied comparison for Zydus Lifesciences Ltd.?

Ans. The supplied peer comparison includes Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital, Panacea Biotec, Sai Parenteral's, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies, all from the broader Healthcare space.

What should investors monitor next in Zydus Lifesciences Ltd. Share Price?

Ans. Investors can monitor whether Zydus Lifesciences Ltd. Share Price continues to hold near today’s high of Rs 1,154.50, whether fresh exchange disclosures emerge, and how the stock behaves versus other Healthcare names after this 3.02% gain.